Situation:

How to have a Successful Initial Licensing Meeting. The biopharmaceutical development model incorporates a myriad of opportunities for companies to in-license assets and platforms to augment their drug pipeline. Conversely, these are the same opportunities for (usually smaller) companies to out-license assets and technology in order to stabilize finances, grow awareness in the biopharma space, and allow for more rapid development and expansion of their portfolio of assets. One of the first steps on the road to out-licensing assets or technology by smaller biotech companies is the initial interest meeting. In order to maximize the chances for a successful interaction, a structured process needs to be in place!


NOTE: Use your cursor to scroll or the tool-bar located at the bottom to review all available pages, including example deliverables.


Licensing Facilitation Process

To download the full case study, including example deliverables, click here: Licensing Facilitaion Process


Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.